it's great news. progressing towards phase 3 trial. I am holding small position and waiting to participate to capital raise which is likely to happen after this news in a week or two as they need anywhere between $30-50 million to spend on the phase 3 trials
Ann: First Patient Dosed in Phase 2 Stroke Trial of ARG-007, page-11
-
- There are more pages in this discussion • 39 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AGN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
79.0¢ |
Change
0.005(0.64%) |
Mkt cap ! $101.3M | |||
| Open | High | Low | Value | Volume |
| 79.8¢ | 79.8¢ | 79.0¢ | $1.007K | 1.269K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 10361 | 79.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 80.0¢ | 1489 | 1 |
View Market Depth
| Last trade - 15.15pm 11/09/2024 (20 minute delay) ? |
| AGN (ASX) Chart |